Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Human Cloning Policy Institute Spearheads Global Grassroots Effort to Prevent Therapeutic Cloning Ban at the United Nations

06.11.2003


The Human Cloning Policy Institute (HCPI) launched this week a major grassroots effort to head off a proposed ban on therapeutic cloning in the United Nations scheduled for vote this Thursday. The total ban is sponsored by Costa Rica and is supported by the United States. The Human Cloning Policy Institute is backed by Ian Wilmut (Dolly’s cloner), some of the world’s leading scientists, physicians and international law experts, including retired World Court judge, C.G. Weeramantry.

HCPI executive director, Bernard Siegel stated, “It is the widespread belief of leading scientists and medical researchers that failure to proceed with SCNT stem cell research is the equivalent to turning our backs on one of the greatest potential medical advances of our time and would thereby destroy the hope for understanding and treatment of many deadly diseases and conditions. A consequence of banning SCNT research might be to condemn millions of adults and children to premature death or a life of intense misery and suffering.”

HCPI has urged its supporters and allied organizations, including disease advocates, private citizens, members of biotechnology organizations, physicians, lawyers and members of the scientific research community, to support passage of UN initiatives outlawing human reproductive cloning, but which allow for the promise of SCNT. It opposes the Costa Rican proposed convention, which bans SCNT research and urges support for the rival Belgium compromise convention, which encourages member states to ban reproductive cloning, but would not ban SCNT internationally.



HCPI further urges support for the World Court Initiative asking the General Assembly to seek an advisory opinion from the International Court of Justice declaring human reproductive cloning (only) a crime against humanity. Siegel stated, “By sponsoring the World Court Initiative, HCPI seeks that the World Court strip away any vestige of legitimacy from potential human cloners, such as Zavos and Antinori. A declaration that human reproductive cloning is a crime against humanity will prompt all member states to crack down on those activities and serve as a lasting deterrent.”

Siegel further commented, “Human reproductive cloning activities performed by unscrupulous scientists are human experimentation. No individual scientist, corporation, business enterprise or nation has the moral or legal warrant to clone human beings. It is extremely important to recognize the difference between reproductive and therapeutic cloning. Informed scientific opinion worldwide supports therapeutic cloning of stem cells. The American Medical Association, the National Academy of Sciences, the Association of American Universities, and many other medical, scientific, and educational associations endorse therapeutic cloning.”

Supporters of HCPI have been urged to email the UN missions at mission@un.org, to express their views on the current proposals. Organizations allied with HCPI on this initiative include the Stem Cell Action Network (SCAN) which has emailed a petition to all UN missions, signed by 2,200 teachers and scientists in medical schools and university science departments across the United States in favor of therapeutic cloning research. The Committee for Advancement of Stem Cell Research (CASCR) also supports the initiative. Both organizations are members of the Coalition for the Advancement of Medical Research.

Frank Cocozzelli, CASCR executive director, who suffers from a form of muscular dystrophy said, “Along with millions of other world citizens who are disabled, suffering from a catastrophic illness or both, SCNT offers me one of the first real rays of hope of being healed.”

The Human Cloning Policy Institute (HCPI) is a nonprofit organization dedicated to advocacy, education and policies against reproductive cloning, while preserving SCNT (therapeutic cloning) which holds the promise of understanding and treating some of man’s deadliest diseases.

HCPI’s principal supporters are leading stem cell scientists, researchers and physicians, who are members of the group’s science and medical advisory boards. A partial list includes: Dr. Ian Wilmut (Roslin Institute), Dr. Rudolf Jaenisch (Whitehead Institute- MIT), Dr. Douglas Melton (Harvard), Dr. Lawrence Goldstein (UCSD), Dr. Gerald Schatten (Magee College), Dr. Alan Trounson ( Monash- Australia), Camillo Ricordi, MD (Diabetes Research Institute), Dr. Helena Edlund (Sweden), Dr. W.Dalton Dietrich (Miami Project to Cure Paralysis), Joe Massey, MD. (Reproductive expert-Atlanta), Judith Grossberg, M.D. (pediatrics-MCV),Doris Rapp, MD ( best-selling author), Sidney Ikpe (International Hospital Relief Foundation), Torrey Brown, MD (Intralytix, Inc., Baltimore) and Dr. Barry Smernoff (Cleveland).

HCPI also has the support of a human rights-legal advisory board that includes retired World Court Judge Christopher Weeramantry (Sri Lanka), law professor Richard Falk (Princeton-UCSB), Peter Ludwig (Darby & Darby-New York) and Nihal Jayawickrama (University of London, School of Economics).

Bernard Siegel | alfa
Further information:
http://www.clonelaw.org

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>